Fig. 8From: A nomogram model based on pre-treatment and post-treatment MR imaging radiomics signatures: application to predict progression-free survival for nasopharyngeal carcinomaDecision curve analysis for clinical and radiomics nomogram models in the training A, C and validation cohorts B, D. The red line represented the net benefit. The x-axis represented high-risk threshold probability. The purple line and blue line represented net benefit of the clinical model and clinical-and-radiomics nomogram, respectivelyBack to article page